Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (3 ops.)
Latest filing published 04 Feb 2014 for INVITROGEN CORP, €155k.
Insider track record
Disclosed buys
6
Disclosed sells
3
Signal history
No signal scores available.
Closed purchases
Market purchases
6
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
George F. Adam Jr.: trading record in brief
George F. Adam Jr. is a declared insider at 2 companies; the most frequent names are Invitrogen Corp and Applera Corp. In total, 21 filings cover trades dated from 3 December 2007 to 3 February 2014.
The open-market side counts 6 purchases for €32k alongside 3 sales for €290k. On balance, insiders were net sellers of €258k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 9 share grants and 1 option exercise.
A typical purchase (the median) is worth €4,880.
The newest entry dates from 4 February 2014: a transaction of €155k, in Invitrogen Corp. The clock since the last published purchase (26 May 2009) now reads 6,359 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to George F. Adam Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
2,747 shares@ US$76.13Common StockSEC:0001127602-14-004235:0
7,828 shares@ US$39.22Common StockSEC:0001127602-11-010063:0
690 shares@ US$51.11Common StockSEC:0001127602-11-010063:1
5,838 shares@ US$51.12Common StockSEC:0001127602-11-010063:2
1,300 shares@ US$51.14Common StockSEC:0001127602-11-010063:3
200 shares@ US$36.68Common StockSEC:0001181431-09-026891:0
Canonical exit: 6 Aug 2009 (T+90)
300 shares@ US$36.68Common StockSEC:0001181431-09-026891:1
Canonical exit: 6 Aug 2009 (T+90)
200 shares@ US$36.69Common StockSEC:0001181431-09-026891:2
Canonical exit: 6 Aug 2009 (T+90)
200 shares@ US$28.00Common StockSEC:0001181431-09-015602:0
Canonical exit: 9 Jun 2009 (T+90)
200 shares@ US$27.99Common StockSEC:0001181431-09-015602:1
Canonical exit: 9 Jun 2009 (T+90)
200 shares@ US$28.05Common StockSEC:0001181431-09-015602:2
Canonical exit: 9 Jun 2009 (T+90)
3,484 sharesApplied Biosystems Group Common StockSEC:0000077551-08-000100:0
239 shares@ US$36.57Applied Biosystems Group Common StockSEC:0000077551-08-000075:0
214 shares@ US$34.69Applied Biosystems Group Common StockSEC:0000077551-08-000064:0
101 shares@ US$12.80Celera Group Common StockSEC:0000077551-08-000064:1
216 shares@ US$33.97Applied Biosystems Group Common StockSEC:0000077551-08-000058:0
103 shares@ US$13.60Celera Group Common StockSEC:0000077551-08-000058:1
2,600 shares0Applied Biosystems Group Common StockSEC:0000077551-07-000278:0
1,000 shares0Celera Group Common StockSEC:0000077551-07-000278:1
19 of 19 declarations
